HB 710 Kentucky House · 2025 Regular Session

AN ACT relating to licensees authorized to prescribe or dispense controlled substances.

HB 710 amends Kentucky's medical licensing law (KRS 311.586) to replace gendered terms like "he or she" with gender-neutral language in physician reporting requirements. It directly affects all physicians and osteopaths in Kentucky who must report their office addresses to the licensing board. The bill makes a technical update to existing language without changing any substantive obligations or creating new requirements.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2025
Committee Review
Mar 2025
House Passage
Mar 2025
Senate Passage
Governor
Introduced Feb 19, 2025 Last action Mar 6, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Current/Final · 7 edits
MODERATE
This bill significantly broadens the scope of Kentucky's controlled substance reporting and prescribing regulations. It expands the requirement to include all licensees authorized to prescribe or dispense controlled substances, not just physicians. The bill establishes new reporting requirements between agencies and adds specific prescribing limits for Schedule II substances, particularly for acute pain treatment.
Scope change
Expanded from only physicians practicing medicine or osteopathy to all licensees authorized to prescribe or dispense controlled substances, including nurses, dentists, optometrists, podiatrists, and other regulated healthcare providers.
SCOPE

Expanded applicability from physicians only to all healthcare licensees authorized to prescribe or dispense controlled substances

DEFINITION

Created new definitions for 'reporting agency' and 'state licensing board' to clarify which entities must participate in the reporting system

REQUIREMENT

Added mandatory reporting of improper prescribing or dispensing between agencies within three business days

Established new prescribing limits for Schedule II substances, prohibiting prescriptions for more than three days for acute pain conditions

Added prohibition on dispensing more than 48 hours of Schedule II or hydrocodone-containing Schedule III substances outside of narcotic treatment programs

Required state licensing boards to establish mandatory prescribing and dispensing standards through administrative regulation

ENFORCEMENT

Added requirement for county attorneys to notify Attorney General and licensing boards within three days of felony indictments involving controlled substances

Floor votes · House Mar 6, 2025

How they voted

8118
Passed · 5 other
Total votes 104
Mar 6, 2025
D Democratic21
3 Yea 18 Nay
85% Nay
R Republican83
78 Yea 5
93% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
15
Key actions
2
Committee
4
Mar 6, 2025
Committee
to Committee on Committees (S)
upper
Mar 6, 2025
Lower · Passed
3rd reading, passed 77-18 with Committee Substitute (1) and Committee Amendment (1-title)
lower
Mar 5, 2025
Lower · Passed
reported favorably, to Rules with Committee Substitute (1) and Committee Amendment (1-title)
lower
Feb 27, 2025
Committee
to Health Services (H)
lower
Feb 19, 2025
Committee
to Committee on Committees (H)
lower
Feb 19, 2025
Introduced
introduced in House
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.